Immune infiltration scores suggest a positive correlation between IRF1 and immune infiltration in tumors like breast cancer, renal cancer, and cutaneous melanoma; however, no such correlation exists in AML, indicating that IRF1 may function uniquely in AML compared with other types of tumors. The gene discussed is IRF1; the disease is renal carcinoma.